Taiko Pharmaceutical Co.,Ltd. (4574.T) JPX

Currency In JPY

AD

Taiko Pharmaceutical Co.,Ltd.

Address

1-4-1, Nishi-Honmachi

Osaka, 550-0005

Japan

Phone

81 6 4391 1110

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

214

First IPO Date

March 18, 2009

Key Executives

NameTitlePayYear Born
Takashi ShibataPresident, Chief Executive Officer & Representative Director116.39M1956
Shinichi SekiExecutive Officer & GM of Infection Control Business Development Division0N/A
Tsuyoshi HonmaExecutive Officer of Accounting & IT0N/A
Keizo NakadaExecutive Officer0N/A
Takatoshi OsadaSenior Executive Officer of Marketing & Sales0N/A
Konosuke TanakaExecutive Officer of Personnel Affairs & Public Relations0N/A
Mitsuhiro YamashitaExecutive Officer of Overseas Business0N/A
Masaji HashimotoSenior Managing Director & Director01967
AD

Description

Taiko Pharmaceutical Co.,Ltd. operates primarily in the pharmaceutical sector and the field of infection prevention. The company manufactures and distributes various over-the-counter medications, including its well-known Seirogan and Seirogan Toi-A brands, which are formulated to alleviate symptoms such as loose stools, diarrhea, vomiting, and ailments stemming from food or water contamination. Additionally, it provides specific tablets for diarrhea relief and quasi-pharmaceuticals like the Trumpet Intestinal Regulator BF. In its infection control segment, Taiko Pharmaceutical produces and supplies a range of sanitation products under the Cleverin brand to wholesalers. This includes the Cleverin generator, a device engineered to emit low concentrations of chlorine dioxide gas. The company also leverages its proprietary Cleverin technology by supplying it through original equipment manufacturer (OEM) agreements and engaging in joint product development ventures with other businesses. Its products are exported to several countries, including the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was founded in 1946 and is headquartered in Osaka, Japan.

AD